Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 355

    1.

    Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations.

    Equitani F, Fernandez-Real JM, Menichella G, Koch M, Calvani M, Nobili V, Mingrone G, Manco M.

    Diabetes Care. 2008 Jan;31(1):3-8. Epub 2007 Oct 24.PMID: 17959863 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations: response to Equitani et al.

    Valenti L, Dongiovanni P, Fracanzani AL, Fargion S.

    Diabetes Care. 2008 Mar;31(3):e18; author reply e19. No abstract available. PMID: 18308681 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.

    Tripathy D, Carlsson AL, Lehto M, Isomaa B, Tuomi T, Groop L.

    Diabetologia. 2000 Dec;43(12):1476-83.PMID: 11151756 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical expression and insulin sensitivity in type 2 diabetic patients with heterozygous mutations for haemochromatosis.

    Van Lerberghe S, Hermans MP, Dahan K, Buysschaert M.

    Diabetes Metab. 2002 Feb;28(1):33-8.PMID: 11938026 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Study of circulating prohepcidin in association with insulin sensitivity and changing iron stores.

    Fernández-Real JM, Equitani F, Moreno JM, Manco M, Ortega F, Ricart W.

    J Clin Endocrinol Metab. 2009 Mar;94(3):982-8. Epub 2008 Dec 30.PMID: 19116239 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Molecular genetic diagnostics and screening of hereditary hemochromatosis]

    Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.

    Vnitr Lek. 2006 Jun;52(6):602-8. Slovak. PMID: 16871764 [PubMed - indexed for MEDLINE]Related articles

    7.

    Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.

    Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, Fargion S.

    Am J Gastroenterol. 2007 Jun;102(6):1251-8. Epub 2007 Mar 27.PMID: 17391316 [PubMed - indexed for MEDLINE]Related articles

    8.

    Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis.

    Valenti L, Dongiovanni P, Fracanzani AL, Santorelli G, Fatta E, Bertelli C, Taioli E, Fiorelli G, Fargion S.

    Dig Liver Dis. 2003 Mar;35(3):172-8.PMID: 12779071 [PubMed - indexed for MEDLINE]Related articles

    9.

    Relations among serum ferritin, C282Y and H63D mutations in the HFE gene and type 2 diabetes mellitus in the Czech population.

    Kanková K, Jansen EH, Márová I, Stejskalová A, Pácal L, Muzík J, Vácha J.

    Exp Clin Endocrinol Diabetes. 2002 Aug;110(5):223-9.PMID: 12148086 [PubMed - indexed for MEDLINE]Related articles

    10.

    Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.

    Bugianesi E, Manzini P, D'Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M.

    Hepatology. 2004 Jan;39(1):179-87.PMID: 14752836 [PubMed - indexed for MEDLINE]Related articles

    11.

    Factors affecting glucose tolerance in hereditary hemochromatosis.

    Hramiak IM, Finegood DT, Adams PC.

    Clin Invest Med. 1997 Apr;20(2):110-8.PMID: 9088667 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical characteristics of type 2 diabetes in patients with mutations of HFE.

    Dubois-Laforgue D, Caillat-Zucman S, Boitard C, Timsit J.

    Diabetes Metab. 2000 Feb;26(1):65-8.PMID: 10705106 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis.

    Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA.

    Endocrinology. 2004 Nov;145(11):5305-12. Epub 2004 Aug 12.PMID: 15308612 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Tumor necrosis factor-alpha -308G>A allelic variant modulates iron accumulation in patients with hereditary hemochromatosis.

    Krayenbuehl PA, Maly FE, Hersberger M, Wiesli P, Himmelmann A, Eid K, Greminger P, Vetter W, Schulthess G.

    Clin Chem. 2006 Aug;52(8):1552-8. Epub 2006 Jun 22.PMID: 16793930 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis.

    Abraham D, Rogers J, Gault P, Kushner JP, McClain DA.

    Diabetologia. 2006 Nov;49(11):2546-51. Epub 2006 Sep 22.PMID: 17019598 [PubMed - indexed for MEDLINE]Related articles

    16.

    Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity.

    Fernández-Real JM, Moreno JM, López-Bermejo A, Chico B, Vendrell J, Ricart W.

    Diabetes Care. 2007 Mar;30(3):604-8.PMID: 17327328 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.

    Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, Phung Y, Ganz T, Camaschella C.

    Blood. 2007 Dec 1;110(12):4096-100. Epub 2007 Aug 27.PMID: 17724144 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance.

    Stancáková A, Pihlajamäki J, Kuusisto J, Stefan N, Fritsche A, Häring H, Andreozzi F, Succurro E, Sesti G, Boesgaard TW, Hansen T, Pedersen O, Jansson PA, Hammarstedt A, Smith U, Laakso M; EUGENE2 Consortium.

    J Clin Endocrinol Metab. 2008 May;93(5):1924-30. Epub 2008 Feb 19.PMID: 18285412 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Normal glucose tolerance and gestational diabetes mellitus: what is in between?

    Di Cianni G, Seghieri G, Lencioni C, Cuccuru I, Anichini R, De Bellis A, Ghio A, Tesi F, Volpe L, Del Prato S.

    Diabetes Care. 2007 Jul;30(7):1783-8. Epub 2007 Apr 6.PMID: 17416793 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.

    Walsh A, Dixon JL, Ramm GA, Hewett DG, Lincoln DJ, Anderson GJ, Subramaniam VN, Dodemaide J, Cavanaugh JA, Bassett ML, Powell LW.

    Clin Gastroenterol Hepatol. 2006 Nov;4(11):1403-10. Epub 2006 Sep 18.PMID: 16979952 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data